Who are pharma's true VIPs?

You mean you don't know? Helpfully, a trade magazine has ranked them for you. The 40 most influential people in pharma--and they're not always the people you'd expect. In fact, FDA Commissioner Andy von Eschenbach didn't make the list. Who did? Carl Icahn, for one. The highest ranking CEO was (drum roll, please) Genentech's Arthur Levinson at the number two spot. GlaxoSmithKline's new CEO Andrew Witty came in came in at number six. Other familiar names include Bill and Melinda Gates (3), Janet Woodcock (18), Warren Buffett (25)and J. Craig Venter (27). You'll have to read the list to get the rest.

- check out the list and article in World Pharmaceuticals (.pdf)
- see the Pharmalot item 

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.